BBNX
Beta Bionics, Inc. Common Stock
NASDAQ: BBNX · HEALTHCARE · MEDICAL DEVICES
$9.90
-1.79% today
Updated 2026-04-29
Market cap
$441.16M
P/E ratio
—
P/S ratio
4.00x
EPS (TTM)
$-1.37
Dividend yield
—
52W range
$9 – $33
Volume
1.2M
Beta Bionics, Inc. Common Stock (BBNX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 6
Last 6 quarters
Avg EPS surprise
-20.0%
Last 4 quarters
Revenue YoY growth
+57.1%
Most recent quarter
EPS YoY growth
+89.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+10.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+19.8%
2025-07-29
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-17 | $-0.30 | +21.1% | $13.94 | $13.61 | -2.4% |
| 2025-10-28 | $-0.33 | +13.2% | $23.75 | $26.79 | +12.8% |
| 2025-07-29 | $-0.39 | +7.1% | $13.99 | $16.76 | +19.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.38 | $-0.30 | +21.1% | $32.12M | +57.1% |
| 2025-09-30 | $-0.38 | $-0.33 | +13.2% | $27.25M | +63.1% |
| 2025-06-30 | $-0.42 | $-0.39 | +7.1% | $23.24M | — |
| 2025-03-31 | $-0.42 | $-0.93 | -121.4% | $17.64M | — |
| 2024-12-31 | $-1.22 | $-2.72 | -123.6% | $20.44M | — |
| 2024-09-30 | $0.00 | $-0.82 | — | $16.70M | — |
Frequently asked questions
Has Beta Bionics, Inc. Common Stock beaten earnings estimates?
Beta Bionics, Inc. Common Stock has beaten Wall Street EPS estimates in 3 of its last 6 quarterly reports, with an average EPS surprise of -20.0% over the last 4 quarters.
How does BBNX stock react to earnings?
BBNX stock has moved an average of +10.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Beta Bionics, Inc. Common Stock's revenue growth rate?
Beta Bionics, Inc. Common Stock reported year-over-year revenue growth of +57.1% in its most recent quarter, with EPS growing +89.0% year-over-year.